An Open-Label, Multicenter, Parallel-Group, Two-Arm Study Comparing the Pharmacokinetics of Keppra XR in Children (Aged 12 - 16 Years Old) With Epilepsy and in Adults (Aged 18 - 55 Years Old) With Epilepsy
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2015
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB
- 24 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2010 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 15 Dec 2009 Planned end date changed from Apr 2011 to Apr 2010 as reported by ClinicalTrials.gov.